Joslyn Kirby, MD sits down with Dermcast.tv for discussion about the management of the alopecia patient. Hair, or lack thereof, can be a direct measure of attractiveness. Alopeica patients often struggle with the stigma associated with their hair loss. Dr. Kirby talks about using dermoscopy in the treatment process, and covers the different treatment options …
Alopecia areata (AA) is considered the most common autoimmune disease in humans with an estimated prevalence of 1 in 1000. Patients who have alopecia areata may present with acute or chronic patches of nonscarring hair loss. The hair loss of AA can range from a single patch to full body hair loss and can have …
Ginette Okoye, MD visits the Dermcast.tv studio for an in-depth discussion about the psychosocial impacts of, and diagnostics and treatment regimens for alopecia.
The forms of alopecia where the hair follicle is destroyed are considered scarring, while others types do not destroy the follicle and are therefore non-scarring. Examples of scarring alopecia are lichen planopilaris (LPP) or discoid lupus erythematosus (DLE), and non-scarring alopecia includes alopecia areata, androgenetic alopecia (AGA), syphilis, and trichotillomania. The ability to differentiate should …
So-called ‘hedgehog pathway inhibitors’ (HPI) such as vismodegib and sonidegib are effective therapies for treating basal cell carcinoma (BCC). HPI target overactive signals in the hedgehog molecular pathway that lead to the proliferation of cancer cells. However, when inhibiting the cancer cells, HPI also inhibit hair follicle (HF) growth which leads to hair loss in …